These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8461467)

  • 21. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.
    DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R
    Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation.
    June RA; Schade SZ; Bankowski MJ; Kuhns M; McNamara A; Lint TF; Landay AL; Spear GT
    AIDS; 1991 Mar; 5(3):269-74. PubMed ID: 1829367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection.
    Müller S; Wang H; Silverman GJ; Bramlet G; Haigwood N; Köhler H
    Scand J Immunol; 1993 Oct; 38(4):327-34. PubMed ID: 7692591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir.
    Moir S; Lapointe R; Malaspina A; Ostrowski M; Cole CE; Chun TW; Adelsberger J; Baseler M; Hwu P; Fauci AS
    J Virol; 1999 Oct; 73(10):7972-80. PubMed ID: 10482544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of opsonized HIV entry in normal B lymphocytes.
    Legendre C; Gras G; Krzysiek R; Galanaud P; Richard Y; Dormont D
    FEBS Lett; 1996 Mar; 381(3):227-32. PubMed ID: 8601461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process.
    Chowdhury MI; Koyanagi Y; Suzuki M; Kobayashi S; Yamaguchi K; Yamamoto N
    Virus Genes; 1992 Jan; 6(1):63-78. PubMed ID: 1347963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects.
    Eyeson J; King D; Boaz MJ; Sefia E; Tomkins S; Waters A; Easterbrook PJ; Vyakarnam A
    AIDS; 2003 Nov; 17(16):2299-311. PubMed ID: 14571181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro.
    Tóth FD; Mosborg-Petersen P; Kiss J; Aboagye-Mathiesen G; Zdravkovic M; Hager H; Aranyosi J; Lampé L; Ebbesen P
    Clin Exp Immunol; 1994 Jun; 96(3):389-94. PubMed ID: 8004808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells.
    Debiaggi M; Bruno R; Carlevari M; Achilli G; Emanuelli B; Cereda PM; Romero E; Filice G
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):287-96. PubMed ID: 7742042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.
    Matsuda S; Gidlund M; Chiodi F; Cafaro A; Nygren A; Morein B; Nilsson K; Fenyö EM; Wigzell H
    Scand J Immunol; 1989 Oct; 30(4):425-34. PubMed ID: 2554488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells.
    Heinkelein M; Sopper S; Jassoy C
    J Virol; 1995 Nov; 69(11):6925-31. PubMed ID: 7474110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro.
    Robinson WE; Kawamura T; Lake D; Masuho Y; Mitchell WM; Hersh EM
    J Virol; 1990 Nov; 64(11):5301-5. PubMed ID: 1698995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies.
    Hinkula J; Bratt G; Gilljam G; Nordlund S; Broliden PA; Holmberg V; Olausson-Hansson E; Albert J; Sandström E; Wahren B
    J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):940-51. PubMed ID: 8051620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies.
    Sullivan N; Sun Y; Binley J; Lee J; Barbas CF; Parren PW; Burton DR; Sodroski J
    J Virol; 1998 Aug; 72(8):6332-8. PubMed ID: 9658072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of serum antigen and antibody concentration with clinical features in HIV infection.
    Ellaurie M; Rubinstein A
    Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism for complement-mediated, antibody-dependent enhancement of human immunodeficiency virus type 1 infection in MT2 cells is enhanced entry through CD4, CD21, and CXCR4 chemokine receptors.
    Robinson WE
    Viral Immunol; 2006; 19(3):434-47. PubMed ID: 16987062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymerase chain reaction-based assay for antibody-mediated neutralization of HIV-1 reveals a population of nonneutralized virus undetected by conventional p24 assay.
    Achkar JM; Wang XH; Nyambi P; Gorny MK; Zolla-Pazner S; Bandrés JC
    J Acquir Immune Defic Syndr; 2000 Jul; 24(3):203-10. PubMed ID: 10969343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 (HIV-1) genomic sequences and distinct changes in CD8+ lymphocytes precede detectable levels of HIV-1 antibodies in high-risk homosexuals.
    Yagi MJ; Joesten ME; Wallace J; Roboz JP; Bekesi JG
    J Infect Dis; 1991 Jul; 164(1):183-8. PubMed ID: 1829106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of CD4+ T cells harboring human immunodeficiency virus type 1 DNA by flow cytometry using simultaneous immunophenotyping and PCR-driven in situ hybridization: evidence of epitope masking of the CD4 cell surface molecule in vivo.
    Patterson BK; Goolsby C; Hodara V; Lohman KL; Wolinsky SM
    J Virol; 1995 Jul; 69(7):4316-22. PubMed ID: 7539507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.